Affordable and Expert Chronic Lymphocytic Leukemia Care in India

Chronic Lymphocytic Leukemia care in India combines expert specialists, modern therapies, and affordable treatment plans tailored for international patients.

Affordable and Expert Chronic Lymphocytic Leukemia Care in India

Chronic lymphocytic leukemia treatment

Chronic lymphocytic leukemia (CLL) is a lymphocytic blood cancer malignancy that afflicts the lymphocyte, i.e. white blood cells fighting infections. It normally advances at a slow rate as compared to other types of leukemia.

What is CLL?

  • A malignancy of B lymphocytes (a form of white blood cell).
  • Results in the formation of excess abnormal lymphocytes that would drive away healthy blood cells.
  • Has occurred frequently among the aged, more generally among men than among women.

Treatment Options

  • CLL does not require treatment in all affected. Many are observed until symptoms develop or blood counts get worse.

Treatment is required in cases whereby options are:

  • Targeted therapy (what is done today)
  • Bruton tyrosine kinase (BTK) inhibitors (ibrutinib, acalabrutinib)
  • BCL-2 inhibitor (venetoclax)
  • Monoclonal antibodies (rituximab, obinutuzumab)
  • Chemotherapy (Less common now)
  • Stem cell transplant (very rare, used on younger/high-risk patient cases)

Best hospitals for chronic lymphocytic leukemia

Chronic lymphocytic leukemia treatment in India

Observation ("Watch and Wait")

  • Not everyone with early stage CLL requires urgent management provided he does not have the symptoms.
  • Monitoring of high blood counts and other body statistics is done regularly by doctors.
  • Treatment is instituted in only case the disease progresses or the symptoms manifest themselves

When Treatment is Applied

  • It is mostly treated once the symptoms have occurred.
  • Suddenly increasing counts of lymphocytes
  • Symptomatic enlargement of the lymph nodes, the splenic or hepatic organs
  • Anemia or low Platelets because of CLL
  • B symptoms (fever, night sweats, weight loss, fatigue)

Targeted Therapy (is preferred as first-line in most cases)

The medicine inhibits certain cancer cell processes:

  • BTK blockers: Ibrutinib, acalabrutinib, Zanubrutinib
  • BCL-2 inhibitor: Venetoclax (usually together with obinutuzumab)
  • They are oral medications which have to a large extent replaced chemotherapy on a number of patients.

Monoclonal Antibody Therapy

  • Anti-CD20: Rituximab, Obiutuzumab, Ofatumumab
  • Usually administered together with specific therapy or chemotherapy.
  • They assist in the destruction of leukemia cells by immune system

Chemotherapy (Not as Common anymore)

  • These are the standard of care, originally the standard treatment, but now receiving less frequent application because of side effects.
  • Examples are Fludarabine, Cyclophosphamide, Bendamustine.
  • Rituximab Combination Therapy (normally occurring with Rituximab, or FCR regimen).
  • More frequently applied on young and fit patients or when the newer drugs are not available.

Stem Cell Transplant (Not Used Often)

  • Allogeneic stem cell transplant is an option in high risk, refractory CLL that involves young patients.
  • Can come along with a lot of risk, so should be used in selected instances.

Encouraging & Symptom Control

  • Infections: Preventative antibiotics, anti virals, anti fungals when necessary
  • Immunoglobulin replacement: This is done to patients with recurrent infections
  • Blood transfusions: When Bleeding is due to anemia or low number of Platelets
  • Vaccinations: pneumococcal and the flu (Use non-live vaccinations)

Clinical Trials

  • Future research involves cell-based approaches that use CAR T-cells, development of new BTK inhibitors, and combination therapy.
  • Trial participation can be of benefit to patients with relapsed or high-risk CLL.

Chronic lymphocytic leukemia diagnosis

A straight forward explanation of the diagnosis of the Chronic Lymphocytic Leukemia (CLL) is as follows:

History and Physical Exam

  • Doctor will also examine the symptoms like fatigue, night sweats, weight loss or frequent infections.
  • Examination may involve checking of lymph nodes which are swollen, enlarged spleen or liver.

Blood Tests

  • The primary test of CLL is referred to as a complete blood count (CBC):
  • Increased number of lymphocytes (lymphocytosis): a characteristic feature of CLL (more than 5,000 lymphocyte/ microliter in at least 3 months).
  • Low red cells or platelets can be an indication of late-stage disease

Laboratory: Flow Cytometry (Immunophenotyping)

  • Lends credence to diagnosis by examining proteins on the cell surface of the lymphocytes.
  • The CLL cells tend to express CD5, CD19, CD20 (dim) and CD23.
  • Aids in differentiating CLL with other lymphoma or leukemia.

Bone Marrow Aspiration / Biopsy

Not always necessary, but can be performed to:

  • Assess bone marrow involvement
  • Essay low blood counts
  • Assist in the treatment planning

Genetic /Molecular Tests

These tests will give prognostic and will direct therapy:

  • FISH (Fluorescence in situ hybridization) detects chromosomal abnormalities
  • Commons: del( 13q), trisomy 12, del( 11q), del( 17p)
  • P53 genotyping: predicts inefficiency in chemotherapy
  • IGHV mutation status: better prognosis = mutated IGHV

Imaging (Sometimes Used)

  • CT scans or ultrasonography is possible in case of large internal lymph nodes or where there is enlargement of the spleen
  • Not required to diagnose.

Differential Diagnosis

Physicians already exclude conditions that may closely resemble CLL:

  • Other non-Hodgkin lymphomas (mantle cell lymphoma, hairy cell leukemia)
  • Reactive lymphocytosis (virals)

Chronic lymphocytic leukemia doctors in India

Chronic lymphocytic leukemia treatment in India by GetWellGo

GetWellGo is an online healthcare platform which integrates international patients with the Indian hospitals and oncologists. They offer such services as:

  • References to hospital and doctor sources
  • Full medical evaluation through consulting online
  • Cost estimates
  • Travelling coordination (medical visas, hotel, transport)
  • Case management and appointment booking, including language assistance (English, Croatian, and/or Serbian) and available 24/7

Treatment of Leukemia

  • They are also engaged in helping international CLL patients in providing them with the best hospitals and hematology-oncology specialists in a cost-effective and transparent manner.

CAR T-cell Therapy Support

  • GetWellGo facilitates cutting edge treatments, such as CAR T-cell therapy, which is a newer option in blood cancer care, including end-to-end logistical and clinical assistance.

Why Choose GetWellGo for Chronic lymphocytic leukemia treatment?

GetWellGo is regarded as a leading supplier of healthcare services. We help our foreign clients choose the best treatment locations that suit their needs both financially and medically.

We offer:

  • Complete transparency
  • Fair costs.
  • 24 hour availability.
  • Medical E-visas
  • Online consultation from recognized Indian experts.
  • Assistance in selecting India's top hospitals for chronic lymphocytic leukemia treatment.
  • Expert hemato-oncologists with a strong track record of success
  • Assistance during and after the course of treatment.
  • Language Support
  • Travel and Accommodation Services
  • Case manager assigned to every patient to provide seamless support in and out of the hospital like appointment booking
  • Local SIM Cards
  • Currency Exchange
  • Arranging Patient’s local food

Recent Blogs